Biomatter, a company specialising in customenzyme design, has raised $18 million in an oversubscribed Series A fundinground led by Astanor, with participation from existing investors UVC Partners,Inve...
Biomatter lands $18M to speed up enzyme development with AI
Biomatter, a company specialising in customenzyme design, has raised $18 million in an oversubscribed Series A fundinground led by Astanor, with participation from existing investors UVC Partners,Inve...
- Amount
- $18M
- Round
- Series A
- Company
- Biomatter
From 
Closed a round or launched a fund?
Submit your fund or deal announcement. Approved deals go into the Capstack funding tracker.
